Genicular vs IPACK Block for Analgesia in Knee Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorKocaeli University

About this trial

Total knee arthroplasty (TKA) is one of the most frequently performed orthopedic procedures, and with the aging population, the global number of TKA cases is expected to increase sixfold within the next decade. Postoperative pain following TKA is often severe and difficult to manage, which may increase the risk of developing chronic pain. Effective pain control is therefore a major concern, and multimodal analgesia is recommended to enhance analgesia, reduce opioid consumption, and minimize opioid-related side effects.

Peripheral nerve blocks (PNBs) are an integral part of multimodal regimens. Among them, the adductor canal block (ACB), which provides analgesia to the anteromedial aspect of the knee while preserving motor function, is widely used. The optimal analgesic strategy for TKA should not only ensure adequate pain relief but also maintain quadriceps strength to allow early mobilization. Motor-sparing blocks combined with multimodal analgesia have become increasingly popular because they facilitate early rehabilitation, decrease opioid requirements, and improve recovery outcomes.

The knee joint has a complex innervation, receiving contributions from the femoral, sciatic, and obturator nerves. For this reason, combining different PNBs may provide superior analgesia compared to a single block (2). The genicular nerves, consisting of branches from the femoral, common peroneal, saphenous, tibial, and obturator nerves, innervate the knee capsule. Genicular nerve block specifically targets these branches and has been used to manage postoperative pain in TKA patients.

Another motor-sparing option is the interspace between the popliteal artery and posterior capsule of the knee (IPACK) block, which provides analgesia to the posterior aspect of the knee. Using ultrasound guidance, local anesthetic is deposited between the posterior capsule and the popliteal artery. This approach spares the main trunks of the tibial and common peroneal nerves while effectively blocking the terminal branches innervating the posterior capsule, including the genicular nerves and the popliteal plexus.

However, there are no studies in the literature directly comparing IPACK and genicular blocks. With this study, the investigators aim to compare the efficacy of these two blocks in patients undergoing TKA.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing unilateral total knee arthroplasty

ASA physical status I-III

Disqualifiers

BMI > 35

Patients < 50 kg

Allergy to study medications

Trial design

Design model

Parallel

Treatments tested in this trial

  • IPACK block

    Procedure/Surgery

    After the general anesthesia induction, IPACK block will be performed with 0.25% bupivacaine (20 mL) using ultrasound in addition to adductor canal block.

  • Genicular nerve block with bupivacaine

    Procedure/Surgery

    After the general anesthesia induction, genicular block will be performed with 0.25% bupivacaine (20 mL) using ultrasound in addition to adductor canal block.

Treatment groups

72 Participants
are divided into 2 treatment groups
Group A: IPACK GroupActive comparator 1 intervention
Group B: Genicular GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Morphine consumption

Amount of morphine in the postoperative period (mg)

Time frame
Postoperative day 1 (24th hour)

Secondary outcomes

1

NRS Scores

Numeric Rating Scale scores, between 0-10 (0= no pain, 10=worst pain imaginable)

Time frame
Postoperative day 1 (1st, 6th, 12th and 24th hour)
2

QoR-15

Quality of Recovery-15: 15-item questionnaire that assesses patients' overall quality of recovery, between 0-150.

Time frame
Postoperative 12th day
3

Nausea-vomiting

Number of patients who has nausea or vomiting

Time frame
Postoperative day 1
4

Rescue analgesic

The use of rescue analgesic

Time frame
Postoperative day 1

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: